Victory Capital Management Inc. Takes Position in Phreesia, Inc. (NYSE:PHR)

Victory Capital Management Inc. bought a new stake in Phreesia, Inc. (NYSE:PHR - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 421,820 shares of the company's stock, valued at approximately $10,782,000. Victory Capital Management Inc. owned 0.72% of Phreesia at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. CWM LLC raised its stake in shares of Phreesia by 994.9% in the first quarter. CWM LLC now owns 4,040 shares of the company's stock valued at $103,000 after acquiring an additional 3,671 shares during the period. Arcadia Investment Management Corp MI grew its holdings in shares of Phreesia by 0.7% in the first quarter. Arcadia Investment Management Corp MI now owns 92,770 shares of the company's stock worth $2,371,000 after purchasing an additional 615 shares during the last quarter. Envestnet Asset Management Inc. grew its holdings in shares of Phreesia by 11.1% in the first quarter. Envestnet Asset Management Inc. now owns 23,183 shares of the company's stock worth $593,000 after purchasing an additional 2,325 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Phreesia by 1.0% in the first quarter. Bank of New York Mellon Corp now owns 197,315 shares of the company's stock worth $5,043,000 after purchasing an additional 2,048 shares during the last quarter. Finally, Calamos Advisors LLC bought a new position in shares of Phreesia in the first quarter worth about $1,596,000. Hedge funds and other institutional investors own 92.10% of the company's stock.

Insider Buying and Selling at Phreesia

In other news, SVP David Linetsky sold 2,063 shares of Phreesia stock in a transaction that occurred on Thursday, July 17th. The shares were sold at an average price of $26.89, for a total transaction of $55,474.07. Following the completion of the transaction, the senior vice president directly owned 191,447 shares of the company's stock, valued at $5,148,009.83. The trade was a 1.07% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Evan Roberts sold 1,892 shares of the business's stock in a transaction on Thursday, July 17th. The stock was sold at an average price of $26.89, for a total transaction of $50,875.88. Following the completion of the sale, the chief operating officer directly owned 772,915 shares of the company's stock, valued at approximately $20,783,684.35. The trade was a 0.24% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 53,804 shares of company stock worth $1,510,733. Corporate insiders own 5.50% of the company's stock.

Phreesia Stock Performance

NYSE PHR traded down $0.43 on Friday, hitting $26.62. 360,753 shares of the company's stock traded hands, compared to its average volume of 578,262. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.02. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $30.53. The firm's 50-day moving average price is $26.61 and its two-hundred day moving average price is $26.43. The firm has a market capitalization of $1.58 billion, a PE ratio of -35.97 and a beta of 0.72.

Phreesia (NYSE:PHR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.13) by $0.06. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. The business had revenue of $115.94 million during the quarter, compared to analysts' expectations of $115.00 million. During the same period in the previous year, the business posted ($0.05) EPS. The business's quarterly revenue was up 14.5% compared to the same quarter last year. As a group, analysts expect that Phreesia, Inc. will post -1.1 EPS for the current year.

Analyst Upgrades and Downgrades

PHR has been the topic of several recent research reports. Wall Street Zen upgraded shares of Phreesia from a "hold" rating to a "buy" rating in a report on Sunday, June 1st. Canaccord Genuity Group reduced their price target on shares of Phreesia from $35.00 to $34.00 and set a "buy" rating for the company in a report on Thursday, May 29th. DA Davidson upgraded shares of Phreesia to a "strong-buy" rating in a report on Tuesday. KeyCorp boosted their price target on shares of Phreesia from $28.00 to $35.00 and gave the company an "overweight" rating in a report on Monday, July 14th. Finally, Truist Financial raised their price target on shares of Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a report on Thursday, May 29th. Eleven research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Buy" and an average price target of $32.27.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.